PATENT CLAIM ANALYSIS

Application Number: 16073871
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["514", "152000"]

Abstract:
To provide an agent for overcoming immunosuppression which can overcome immunosuppression by regulatory T cells. An agent for overcoming immunosuppression and an inhibitor of FOXP3 function containing an anthracycline antibiotic as an active ingredient.

Claim (Index 25):
The method of  claim 17 , further comprising another anticancer therapy.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 95.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15074681', '15623585', '14401557', '13582717', '13890042']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6877200649611347
- 35 USC 102 Novelty (BERT): 0.4779578207830487
- Combined Prediction Score: 0.6667438405433261
- Mean Citation Score: 179.020116
- Max Citation Score: 185.79498
- Similarity Product: 149.11478114484788

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test